Full-Time

Analyst - Private Equity Secondaries and Co-Investments

Private Equity, Co-Investments

Posted on 10/3/2025

UBS

UBS

10,001+ employees

Investment bank and wealth, asset manager

No salary listed

London, UK

In Person

Category
Finance & Banking (1)
Required Skills
Investment Banking
Excel/Numbers/Sheets
Financial Modeling
Requirements
  • 2-3 years of experience in Investment Banking / advisory or a PE investment role
  • bachelor’s/master’s degree, ideally with a post-graduate qualification but not mandatory
  • thinker, curious, self-starter, with a keen focus on attention to details and genuine interest for the PE industry
  • adept at articulating analytical views on and off paper, in a concise and confident manner
  • proficient MS Office skills Excel, PPT and LBO modelling proficiency
  • collaborative personality, with the ability to complete tasks independently
  • fluency in a second language will be appreciated
Responsibilities
  • conduct diligence and deal selection of Co-investments, GP and LP led secondary Private Equity opportunities
  • ability to support the deal investment processes, including material production & presentation
  • build and use financial models, third party reports, to evaluate historical information and generate projections
  • convert industry insights into comprehensive investment recommendations and risk assessments
  • be a key contributor to the production of memorandums and recommendations of investment to the Investment Committee
  • support portfolio monitoring, reporting and fundraising efforts
Desired Qualifications
  • fluency in a second language will be appreciated

UBS Group AG is a Swiss multinational financial services firm with four divisions: Global Wealth Management, Personal & Corporate Banking, Asset Management, and the Investment Bank. It serves private, corporate, institutional, and retail clients worldwide, offering wealth planning for high-net-worth individuals, Swiss banking services, a broad range of investment products, and advisory, underwriting, and trading in equities, fixed income, rates, and FX. It earns fees from wealth and asset management, interest income from lending, and trading income from investment banking. Its aim is to help clients manage and grow wealth while delivering diversified, revenue-generating financial services across regions and asset classes.

Company Size

10,001+

Company Stage

IPO

Headquarters

Zurich, Switzerland

Founded

1998

Simplify Jobs

Simplify's Take

What believers are saying

  • Wealth management remains UBS's core profit engine, supporting fee-rich recurring revenue.[2][3]
  • Swiss universal banking and investment banking preserve cross-sell opportunities across clients.[1][4]
  • Asset management and advisory services can benefit from rising demand for portfolio solutions.[2]

What critics are saying

  • Credit Suisse integration continues to consume management attention and trigger layoffs.[4]
  • Market downturns quickly pressure wealth fees and transaction-driven investment bank revenue.[1][5]
  • UBS faces execution risk from reorganizing overlapping roles, systems, and client platforms.[4]

What makes UBS unique

  • UBS combines Swiss universal banking with global wealth management and investment banking.[1][4]
  • UBS serves private, corporate, institutional, and retail clients through four divisions.[1][2]
  • UBS offers traditional and alternative asset capabilities across multiple client channels.[2]

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at UBS who can refer or advise you

Benefits

Flexible Work Hours

Remote Work Options

Professional Development Budget

Growth & Insights and Company News

Headcount

6 month growth

16%

1 year growth

17%

2 year growth

17%
CryptoRobotics
May 8th, 2026
UBS invests $1.5M in XRP through ETFs, marking shift in institutional crypto adoption

UBS has invested $1.5 million in XRP through the Volatility Shares XRP ETF and Grayscale XRP Trust, according to a recent SEC filing. The Swiss bank holds 197,369 shares in the ETF and 317 shares in the trust. The investment represents a strategic approach to cryptocurrency exposure through regulated products rather than direct holdings, reflecting broader institutional trends favouring compliance and risk management. This comes as XRP ETFs experience significant inflows whilst Bitcoin and Ethereum face notable outflows. UBS's move signals growing institutional confidence in XRP and regulated crypto products. The development may encourage retail investors to follow suit, particularly in emerging markets, as traditional financial institutions increasingly participate in the cryptocurrency sector through compliant investment vehicles.

Investors in Healthcare
Apr 13th, 2026
DentaCore secures $168M financing to fuel Swiss dental platform expansion

DentaCore Group, a Swiss dental platform, has secured CHF150 million (US$190 million) in financing to repay existing debt and fund future acquisitions. The package includes a term loan, revolving credit facility and incremental facility. Founded in 2021, DentaCore specialises in acquiring and consolidating dental practices, clinics and laboratories. The company has rapidly scaled to over 60 dental practices and laboratories through more than 40 acquisitions. UBS served as sole mandated lead arranger, bookrunner and agent for a CHF120 million term loan and revolving credit facility. Houlihan Lokey acted as exclusive financing adviser, whilst MLL Legal provided legal counsel. In 2025, Capital Transmission, a Swiss investment company within the BCGE Group, invested in DentaCore.

Sina Finance
Apr 13th, 2026
UBS raises stake in Luye Pharma with $5.1M purchase at $0.37 per share

UBS has increased its stake in Luye Pharma (02186) by 13.95 million shares at approximately HK$2.85 per share, for a total consideration of around HK$39.84 million, according to Hong Kong Stock Exchange filings dated 2 April. Following the transaction, UBS now holds approximately 403 million shares, representing a 10.09% stake in the company. The filing notes that 218.5 million of the reported positions relate to a securities lending agreement executed alongside a convertible bond issuance disclosed on 28 June 2023.

Legal Community
Apr 13th, 2026
Advestra with UBS on CHF 100 m credit to Gasverbund Mittelland - Legalcommunity.ch

Advestra advised UBS Switzerland as coordinator, agent, fronting bank and lender, alongside the other syndicate banks as lenders, on the CHF 100 million credit facility provided to Gasverbund Mittelland, a procurement and grid company of natural and biogas active across the Plateau and Northwestern regions in Switzerland.

Structured Retail Products
Apr 13th, 2026
MerQube secures Series C funding from 7RIDGE and Deutsche Börse to scale derivatives-linked ETF platform

MerQube, a US-based index provider specialising in rules-based and derivatives-enabled strategies, has closed a Series C funding round led by 7RIDGE and Deutsche Börse Group. Existing investors including Allianz Life Ventures, Citi, Intel Capital, J.P. Morgan, Laurion Capital Management and UBS also participated, though the funding amount was not disclosed. The company plans to use the investment to scale its technology platform and expand in derivatives-linked ETF and structured product markets. MerQube focuses on providing customised index solutions and data-driven strategies for institutional clients.

INACTIVE